0 Items - $0.00
Categories
A to Z

Alternative structural projections:

ε-cAMP

1, N⁶- Ethenoadenosine- 3', 5'- cyclic monophosphate ( ε-cAMP ), sodium salt
Fluorescent analogue of cyclic AMP
Cat. No.: E 001
    
CAS No.: [103213-51-0]
Shipping: ambient
Product Name Price (net) Qty
Cat. No.: E 001-10
Unit: 10 µmol / ~3.8 mg
$56.00
For other salt forms or metabolites please inquire. Fluorescent cAMP analogue (λexc 300 nm, λem 415 nm). Detailed technical information and references available. Reference: Secrist et al., Biochemistry, 11, 3499 - 3506 (1972); White et al., Methods Enzymol., 99, 162 - 167 (1983).
Cat. No. E 001
CAS number [103213-51-0]
Purity > 98% HPLC
Salt form Sodium
Storage temperature -20°C / -4°F
Light-sensitive True
Molecular formula C₁₂H₁₁N₅O₆P · Na
Molecular weight [g/mol] 375,2
Modifications 1-cAMP
Target PKA (cAK) Activator
Excitation max [nm] 300
Emission max [nm] 415
Lipophilicity 1.34
Absorption max [nm] 275
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] 6000
  • 1. Jäger R., Russwurm C., Schwede F., Genieser H.-G., Koesling D.Russwurm M., J. Biol. Chem., 287, 1210 - 1219 (2012), "Activation of PDE10 and PDE11 Phosphodiesterases"
  • 2. Schweinsberg S., Moll D., Burghardt N. C., Hahnefeld C., Schwede F., Zimmermann B., Drewianka S., Werner L., Kleinjung F., Genieser H.-G., Schuchhardt J.Herberg F. W., Proteomics, 8, 1212 - 1220 (2008), "Systematic interpretation of cyclic nucleotide binding studies using KinetXBase"
  • 3. Christensen A. E.Doeskeland S. O., Handbook of Cell Signaling Academic Press/Elsevier Science San Diego CA, 2, 549 - 554 (2003), "Cyclic Nucleotide Analogs as Tools to Investigate Cyclic Nucleotide Signaling"
  • 4. Hahnefeld C.Herberg F. W., Abstract of the 13th Protein Kinase Symposium p. 14, 0, 12 - 15 (2002), "cAMP-dependent Protein Kinase: cAMP Analog Screening Using Surface Plasmon Resonance and Fluorescent Methods"
  • 5. Vicentini G. E., Constantin J., Lopez C. H.Bracht A., Biochem. Pharmacol., 59, 1187 - 1201 (2000), "Transport of Cyclic AMP and Synthetic Analogs in the Perfused Rat Liver"
  • 6. Muhonen W. W.Shabb J. B., Protein Sci., 9, 2446 - 2456 (2000), "Resonant Mirror Biosensor Analysis of Type I(Alpha) cAMP-dependent Protein Kinase B Domain-Cyclic Nucleotide Interactions"
  • 7. Krass J. D., Jastorff B.Genieser H.-G., Anal. Chem., 69, 2575 - 2581 (1997), "Determination of Lipophilicity by Gradient Elution High-Performance Liquid Chromatography"
  • 8. Huq I., Dostmann W. R. G.Oegreid D., Biochem. J., 316, 337 - 343 (1996), "Isoleucine 368 is Involved in Low-Affinity Binding of N6-Modified cAMP Analogues to Site B of the Regulatory Subunit of cAMP-Dependent Protein Kinase I"
  • 9. Scott S.-P.Tanaka J. C., Biochemistry, 34, 2338 - 2347 (1995), "Molecular Interactions of 3',5'-Cyclic Purine Analogues with the Binding Site of Retinal Rod Ion Channels"
  • 10. Oegreid D., Ekanger R., Suva R. H., Miller J. P.Doeskeland S. O., Eur. J. Biochem., 181, 19 - 31 (1989), "Comparison of the Two Classes of Binding Sites ( A and B ) of Type I and Type II Cyclic AMP-dependent Protein Kinases Using Cyclic Nucleotide Analogs"
  • 11. Oegreid D., Doeskeland S. O., Gorman K. B.Steinberg R. A., J. Biol. Chem., 263, 17397 - 17404 (1988), "Mutations That Prevent Cyclic Nucleotide Binding to Binding Sites A or B of Type I Cyclic AMP- dependent Protein Kinase"
  • 12. Braumann T.Jastorff B., J. Chromatogr., 350, 105 - 118 (1985), "Physicochemical Characterization of Cyclic Nucleotides by Reversed Phase High-Performance Liquid Chromatography. II. Quantitative Determination of Hydrophobicity"
  • 13. Oegreid D., Doeskeland S. O.Miller J. P., J. Biol. Chem., 258, 1041 - 1049 (1983), "Evidence That Cyclic Nucleotides Activating Rabbit Muscle Protein Kinase I Interact with Both Types of cAMP Binding Sites Associated with the Enzyme"
  • 14. Leonard N. J., CRC Crit. Reviews Biochem., 15, 125 - 199 (1983), "Etheno-substituted Nucleotides and Coenzymes: Fluorescence and Biological Activity"
  • 15. Jastorff B., in: Cell Regulation by Intracellular Signal Molecules St. Swillens ed. 195 - 207 Plenum Press New York London, 0, 0 - 0 (1982), "The Effects of cyclic Nucleotide Derivatives on Cell Metabolism"
  • 16. Miller J. P., Uno H., Christensen L. F., Robins R. K.Meyer R. B., Biochem. Pharmacol., 30, 509 - 515 (1981), "Effect of Modification of the 1-, 2-, and 6-Positions of 9-β-D-Ribofuranosylpurine Cyclic 3',5'- Phosphate on the Cyclic Nucleotide Specificity of Adenosine Cyclic 3',5'- Phosphate and Guanosine Cyclic 3',5'- Phosphate-dependent Protein Kinases"
  • 17. Builder S. E., Baevo J. A.Krebs E. G., J. Biol. Chem., 255, 2350 - 2354 (1980), "Stoichiometry of cAMP and 1,N6-Etheno-cAMP Binding to Protein Kinase"
  • 18. LaPorte D. C., Builder S. E.Storm D. R., J. Biol. Chem., 255, 2343 - 2349 (1980), "Spectroscopic Studies of the cAMP Binding Sites of the Regulatory Subunits of Types I and II Protein Kinase"
  • 19. Nishikori K.Maeno H., J. Biol. Chem., 254, 6099 - 6109 (1979), "Close Relationship between Adenosine 3',5'-Monophosphate-dependent Endogenous Phosphorylation of a Specific Protein and Stimulation of Calcium Uptake in Rat Uterine Microsomes"
  • 20. Free C. A.Paik V. S., Endo, 100, 1287 - 1293 (1977), "Adrenal Stereoidogenic Actions of Cyclic Nucleotide Derivatives in the Rat"
  • 21. Meyer R. B.Miller J. P., Life Sci., 14, 1019 - 1040 (1974), "Analogs of Cyclic AMP and Cyclic GMP: General Methods of Synthesis and the Relationship of Structure to Enzymatic Activity"
  • 22. Secrist J. A., Barrio J. R., Leonard N. J.Weber G., Biochemistry, 11, 3499 - 3506 (1972), "Fluorescent Modification of Adenosine-Containing Coenzymes. Biological Activities and Spectroscopic Properties"

Show more